Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial.
Yongxia WangXinlu WangJianru WangBin LiRui YuYucai HuXingyuan LiGuangcao PengMengmeng ZhangMing-Jun ZhuPublished in: Trials (2020)
This study was registered in the Chinese Clinical Trial Registry on 7 May 2019. The registration number is ChiCRT1900023023 (http://www.chictr.org.cn/showproj.aspx?proj=12370).
Keyphrases
- randomized controlled trial
- clinical trial
- study protocol
- percutaneous coronary intervention
- coronary artery disease
- acute myocardial infarction
- left ventricular
- acute coronary syndrome
- atrial fibrillation
- lymph node metastasis
- heart failure
- st segment elevation myocardial infarction
- open label
- st elevation myocardial infarction
- double blind
- phase iii